Vector image of black body surrounded by white clouds
Multiple Possible Causes of Long COVID Come into Focus
Recent studies have lent support for a variety of hypotheses explaining the debilitating symptoms affecting millions of people after SARS-CoV-2 infection.  
Multiple Possible Causes of Long COVID Come into Focus
Multiple Possible Causes of Long COVID Come into Focus

Recent studies have lent support for a variety of hypotheses explaining the debilitating symptoms affecting millions of people after SARS-CoV-2 infection.  

Recent studies have lent support for a variety of hypotheses explaining the debilitating symptoms affecting millions of people after SARS-CoV-2 infection.  

coronavirus
A surgical mask next to an open pill bottle that’s toppled over, spilling out red capsules meant to represent vitamin D supplements.
Vitamin D Likely Doesn’t Prevent COVID-19, Studies Find
Dan Robitzski | Sep 9, 2022
The results from two large clinical trials don't support the idea that supplements of the vitamin bolster immune defenses against SARS-CoV-2.
the Melbourne skyline with lake in foreground
New Australian Center Will Develop Therapies for Future Pandemics
Shawna Williams | Aug 31, 2022
Launched with a $172 million philanthropic donation and funds from the state of Victoria, the Melbourne-based research institute aims to construct drug discovery platforms to speed the introduction of new therapies.
Small Changes, Big Consequences
Small Changes, Big Consequences
Niki Spahich, PhD
To understand the mechanisms behind severe COVID-19, researchers identified common COVID-19 genetic risk variants that affect immune cell function.
Small vaccine bottles on a conveyer belt
Pfizer and Moderna COVID-19 Omicron Boosters Get OK from the FDA
Catherine Offord | Aug 31, 2022
The immunizations are designed to target the latest Omicron subvariants, and are only authorized for people who have already received their primary vaccinations.
Illustration of several warped and stretched analog clocks swirling around a central point.
It’s Not Just You: Lockdowns Had Us Living in “Blursday,” Study Says
Dan Robitzski | Aug 26, 2022
The Scientist spoke with Maximilien Chaumon about his database showing how COVID-19 related lockdowns warped more 2,800 people’s perception of time.
Characterizing Proteolysis During SARS-CoV-2 Infection
Characterizing Proteolysis During SARS-CoV-2 Infection
The Scientist Creative Services Team in collaboration with Thermo Fisher Scientific
Edward Emmott will discuss mass spectrometry approaches to understand proteolysis during viral infection and their use in developing targeted strategies for COVID-19 treatment.
Anthony Fauci
Anthony Fauci Announces Departure from NIAID, Advisory Roles
Catherine Offord | Aug 22, 2022
The 81-year-old director says that he will step back from his positions this December, but that he will continue working to advance science and public health.
An illustration of a pregnant women wearing a mask, surrounded by microbes
How COVID-19 Affects Pregnancy
Amanda Heidt | Aug 16, 2022
Evidence thus far shows that pregnant people infected with SARS-CoV-2 are at higher risk for severe disease and death, as well as complications in their pregnancies.
Understanding COVID’s Long Game
Understanding COVID’s Long Game
The Creative Services Team in collaboration with Cayman Chemical
Floyd Chilton and Thomas Bumol shine light on the pathways that SARS-CoV-2 hijacks to cause disease.
A translucent illustration of the BA.2.75 subvariant of SARS-CoV-2 against a black background
Experts Mixed on Risk of “Centaurus” Omicron Subvariant
Dan Robitzski | Aug 15, 2022
BA.2.75 is spreading rampantly in India and has so far reached at least 20 other countries, but it doesn’t seem to be outcompeting other Omicron SARS-CoV-2 subvariants.
Four glass vials sit on a reflective tabletop next to a syringe. Each is labeled as a subsequent dose in a four-dose series of COVID-19 vaccines.
What We Know About Getting a Second Booster Shot of COVID-19 Vaccines
Dan Robitzski | Aug 11, 2022
Studies show that a fourth mRNA vaccine dose offers the elderly and other high-risk groups strong protection against hospitalization and death from COVID-19, but experts say benefits for other populations may be more limited.
800x560-october-20-2021
Keeping Pace With SARS-CoV-2 Evolution
The Scientist Creative Services Team in collaboration with Thermo Fisher Scientific
Eugene Koonin and Eric Niederkofler discuss novel technologies to improve viral mutation surveillance.
Countless bats swarming in the evening dusk
Bat Coronaviruses May Infect Tens of Thousands of People Yearly
Andy Carstens | Aug 10, 2022
Parts of Southeast Asia where human and bat population densities are highest could be infection hotspots, a study finds.
Man in lab coat looking at the camera and smiling
Can Taking a Test Now Tell You if You’ve Already Had COVID-19?
Natalia Mesa | Aug 8, 2022
The Scientist asks Brigham and Women’s Hospital infectious disease specialist Lindsey Baden about testing for prior infections.
800x560-misherlock-0916
A New COVID-19 Spit Test Is as Easy as 1-2-3
Roni Dengler, PhD
A device smaller than two stacked decks of cards can reliably detect and discriminate between SARS-CoV-2 variants in spit in less than an hour with results that glow.
EXCLUSIVE
Colorful pills and capsules on a calendar background
Clinical Trial Registry Errors Undermine Transparency
Catherine Offord | Aug 2, 2022
A lack of comprehension among some researchers about how to use ClinicalTrials.gov may be hindering public access to trial information and holding up drug study results, an investigation by The Scientist finds.
metallic-looking illustration of coronavirus structure
How the Omicron Subvariant BA.5 Became a Master of Disguise—and What It Means for the Current COVID-19 Surge
Suresh V. Kuchipudi, The Conversation | Jul 26, 2022
Several mechanisms contribute to the increased transmissibility of this SARS-CoV-2 variant.
Approaches to Processing SARS-CoV-2 Samples for RNA Detection
The Scientist Creative Services Team in collaboration with MilliporeSigma
Discover new RNA extraction and purification strategies and how they enable reliable and sensitive viral detection.
Fluorescent cells in culture connected by tunneling nanotubules
SARS-CoV-2 Could Use Nanotubes to Infect the Brain
Natalia Mesa | Jul 21, 2022
Stressed cells can form hollow actin bridges to neighbors to get help, but the virus may hijack these tiny tunnels for its own purposes, a study suggests.